Merck Alleges Infringement Of Antibacterial Drug

Law360, New York (May 2, 2007, 12:00 AM EDT) -- Pharmaceutical giant Merck & Co. Inc. has sued India’s Ranbaxy Laboratories Ltd. for allegedly infringing its patent for the antibacterial drug Primaxin.

In a complaint filed Monday with the U.S. District Court for the District of Delaware, Merck asked that Ranbaxy be enjoined from marketing a generic version of Primaxin in the United States.

The suit was sparked by Ranbaxy's filing of an Abbreviated New Drug Application to market generic imipenem-cilastatin, a drug that it sells in India. Imipenem-cilastatin contains the active ingredients in the drug...
To view the full article, register now.